Composition for accelerating bone fracture healing

Details Composition for accelerating bone fracture healing Composition for accelerating bone fracture healing

2007-07-19

2010-02-09

Henley, III, Raymond J (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S277000, C514S438000

Reexamination Certificate

active

07659273

ABSTRACT:
A composition for accelerating fracture healing, which has a PDE4 inhibitor as an active ingredient, specifically a composition having a PDE4 inhibitor and a biocompatible and biodegradable polymer is provided, which composition, when formulated into a form suitable for local administration such as a microsphere preparation, can provide a pharmaceutical composition showing an excellent effect in the early healing of bone fracture. The composition is useful in healing of refractory fracture of elderly people and diabetic or osteoporosis patients.

REFERENCES:
patent: 4193926 (1980-03-01), Schmiechen et al.
patent: 4542025 (1985-09-01), Tice et al.
patent: 5000886 (1991-03-01), Lawter et al.
patent: 5171217 (1992-12-01), March et al.
patent: 5223504 (1993-06-01), Noverola et al.
patent: 5288496 (1994-02-01), Lewis et al.
patent: 5294446 (1994-03-01), Schlameus et al.
patent: 5503851 (1996-04-01), Mank et al.
patent: 5552438 (1996-09-01), Christensen, IV
patent: 5605914 (1997-02-01), Muller
patent: 5614515 (1997-03-01), Rodgers et al.
patent: 5804588 (1998-09-01), Dyke et al.
patent: 5910492 (1999-06-01), Hoshino et al.
patent: 5922253 (1999-07-01), Herbert et al.
patent: 5939388 (1999-08-01), Rosen et al.
patent: 6010711 (2000-01-01), O'Keefe et al.
patent: 6011060 (2000-01-01), Laurent et al.
patent: 6197326 (2001-03-01), Suzuki et al.
patent: 6214008 (2001-04-01), Illi
patent: 6451335 (2002-09-01), Goldenheim et al.
patent: 2002/0123520 (2002-09-01), Marfat et al.
patent: 2 278 217 (1998-11-01), None
patent: 100 61 137 (2002-06-01), None
patent: 0 158 380 (1985-10-01), None
patent: 0 163 965 (1985-12-01), None
patent: 0 251 476 (1988-01-01), None
patent: 0 260 817 (1988-03-01), None
patent: 0 432 856 (1991-06-01), None
patent: 0 459 505 (1991-12-01), None
patent: 0 497 564 (1992-08-01), None
patent: 0 557 016 (1993-08-01), None
patent: 0 403 383 (1994-08-01), None
patent: 0 623 607 (1994-11-01), None
patent: 0 738 715 (1996-10-01), None
patent: 0 748 805 (1996-12-01), None
patent: 0 781 548 (1997-07-01), None
patent: 0 848 000 (1998-06-01), None
patent: 0 911 025 (1999-04-01), None
patent: 1 053 746 (2000-11-01), None
patent: 1 308 440 (2003-05-01), None
patent: 56-19324 (1981-05-01), None
patent: 60-67417 (1985-04-01), None
patent: 60-100516 (1985-06-01), None
patent: 62-201816 (1987-09-01), None
patent: 63-091325 (1988-04-01), None
patent: 1-155942 (1989-06-01), None
patent: 01-305929 (1989-12-01), None
patent: 4-364179 (1992-12-01), None
patent: 5-58882 (1993-03-01), None
patent: 5-70363 (1993-03-01), None
patent: 5-194200 (1993-08-01), None
patent: 5-229987 (1993-09-01), None
patent: 6-32732 (1994-02-01), None
patent: 6-211648 (1994-08-01), None
patent: 6-305983 (1994-11-01), None
patent: 07 101861 (1995-04-01), None
patent: 8-151321 (1996-06-01), None
patent: 9-59255 (1997-03-01), None
patent: 9-110678 (1997-04-01), None
patent: 09-169665 (1997-06-01), None
patent: 9-221417 (1997-08-01), None
patent: 9-221418 (1997-08-01), None
patent: 9-263545 (1997-10-01), None
patent: 10-158267 (1998-06-01), None
patent: 10-182499 (1998-07-01), None
patent: 10-226685 (1998-08-01), None
patent: 2001-198208 (2001-07-01), None
patent: WO 90/09783 (1990-09-01), None
patent: WO 91/01720 (1991-02-01), None
patent: WO 91/16314 (1991-10-01), None
patent: WO 92/12961 (1992-08-01), None
patent: WO 92/15282 (1992-09-01), None
patent: WO 93/09118 (1993-05-01), None
patent: WO 94/02465 (1994-02-01), None
patent: WO 94/22852 (1994-10-01), None
patent: WO 94/25437 (1994-11-01), None
patent: WO 95/00516 (1995-01-01), None
patent: WO 95/04045 (1995-02-01), None
patent: WO 95/08534 (1995-03-01), None
patent: WO 95/14667 (1995-06-01), None
patent: WO 95/14681 (1995-06-01), None
patent: WO 95/20578 (1995-08-01), None
patent: WO 95/35282 (1995-12-01), None
patent: WO 96/00215 (1996-01-01), None
patent: WO 96/00218 (1996-01-01), None
patent: WO 96/06843 (1996-03-01), None
patent: WO 96/20698 (1996-07-01), None
patent: WO 96/28143 (1996-09-01), None
patent: WO 96/31485 (1996-10-01), None
patent: WO 97/13502 (1997-04-01), None
patent: WO 97/18208 (1997-05-01), None
patent: WO 97/22585 (1997-06-01), None
patent: WO 97/22586 (1997-06-01), None
patent: WO 97/23457 (1997-07-01), None
patent: WO 97/23547 (1997-07-01), None
patent: WO 97/29750 (1997-08-01), None
patent: WO 97/40032 (1997-10-01), None
patent: WO 97/44036 (1997-11-01), None
patent: WO 97/44322 (1997-11-01), None
patent: WO 98/02440 (1998-01-01), None
patent: WO 98/09961 (1998-03-01), None
patent: WO 98/11113 (1998-03-01), None
patent: WO 98/13348 (1998-04-01), None
patent: WO 98/14432 (1998-04-01), None
patent: WO 98/31674 (1998-07-01), None
patent: WO 98/56431 (1998-12-01), None
patent: WO 99/23076 (1999-05-01), None
patent: WO 99/47186 (1999-09-01), None
patent: WO 99/50270 (1999-10-01), None
patent: WO 99/65474 (1999-12-01), None
patent: WO 00/50011 (2000-08-01), None
patent: WO 00/66584 (2000-11-01), None
patent: WO 01/13953 (2001-03-01), None
patent: WO 01/45705 (2001-06-01), None
patent: WO 01/46136 (2001-06-01), None
patent: WO 01/55112 (2001-08-01), None
patent: WO 01/57025 (2001-08-01), None
patent: WO 01/76575 (2001-10-01), None
patent: WO 01/80835 (2001-11-01), None
patent: WO 01/83594 (2001-11-01), None
patent: WO 01/93909 (2001-12-01), None
patent: WO 02/14280 (2002-02-01), None
patent: WO 02/060875 (2002-08-01), None
patent: WO 02/060898 (2002-08-01), None
Bostrom, Mathias, MD, et al., “Use of Bone Morphogenetic Protein-2 in the Rabbit Ulnar Nonunion Model,” Clinical Orthopaedics and Related Research, No. 327, 1996, pp. 272-282.
Japanese Office Action dated Feb. 3, 2009, issued in Japanese Patent Application No. 2002-591037, 3 pp.
Janetti N. Francischi et al., “Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis,” European Journal of Pharmacology, 399 (2000) 243-249.
Shohei Kasugai et al., “Potential of PDE4 Inhibitors in the Treatment of Osteopenia,” Drug News Perspect 12(9), Nov. 1999.
Shohei Kasugai et al., “Anabolic effect of a phosphodiesterase 4 (PDE4) inhibitor in bone and its possible mechanism,” Jpn. J. of Pharmacol 79, Suppl. 1, 277 (1999).
Ken-ichi Miyamoto et al., Reduction of Bone Loss by Denbufylline, an Inhibitor of Phosphodiesterase 4, Biochemical Pharmacology, 1997, vol. 54, No. 5, 613-617.
Yoshihiro Waki et al., “Effects of XT-44, a Phosphodiesterase 4 Inhibitor, in Osteoblastgenesis and Osteoclastgenesis in Culture and Its Therapeutic Effects in Rat Osteopenia Models,” Jpn. J. Pharmacol. 79, 477-483 (1999).
T. Kinoshita, “Phosphodiesterase Inhibitors, Pentoxifylline and Rolipram, Increase Bone Mass Mainly by Promoting Bone Formation in Normal Mice,”Bone, vol. 27, No. 6 (Dec. 2000) 811-817.
Hitoshi Sezaki, “Drug Delivery System,” Nankodo Co., Ltd. 1986, 185-189 w/trans. p. 185-line 11 to p. 187-line 12.
J. Jpn. Orthop. Assoc. 74(8) 2000 S-1737, S-1735, S-1330, S-1814 with English translations.
J. Jpn. Orthop. Assoc. 73(8) 199 S-1519 with English translations.
Exp. Toxicol. Pathol 45(8) 473-479 (1993/94).
Journal of Bone and Mineral Metabolisum vol. 17(2) 202 (1999) with English translation.
J. Bone and Mineral Res. 14 (Suppl. 1) S349 (1999).
J. Bone and Mineral Res. 14 (Suppl. 1) S354 (1999).
J. Bone and Mineral Res. 14 (Suppl. 1) S504 (1999).
Igaku-Daijiten, 18th Ed., published by Nanzando, pp. 719-720-P1.
Kossetsu Chiryougaku (Fracture Therapeutics), Apr. 2000, pp. 29-37, 46-51, Nanko-do-P2 with English translation.
Proc. Natl. Acad. Sci. USA vol. 87, p. 2220-2224 (1990).
Trends in Pharmacological Sciences, Vo. 11. p. 150-155 (1990).
Advances in Cyclic Nucleotide Research vol. 10, p. 69-92 (1979).
Cellular Signaling vol. 9, Issues 3-4, p. 227-236 (1997).
Journal of Controlled Release 59 p. 77-86 (1999).
Journal of Controlled Release 33 p. 237-243 (1995).
Biomaterials vol. 21 p. 2405-2412 (2000).
International Journal of Pharmaceutics vol. 206 p. 1-12 (2000).
Drug Development and Industrial Pharmacy vol. 24(8) p. 703-727 (1998).
European J. Pharm. Biopharm. vol

Affiliated with

Also associated with

Rating

Composition for accelerating bone fracture healing does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for accelerating bone fracture healing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for accelerating bone fracture healing will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4228137